Profits First: The Story of the Ebola Vaccine

Click here to get this post in PDF

The West African Ebola outbreak claimed over 10,000 lives, but could a Canadian made vaccine have helped saved these lives?

We set out to find out why the vaccine was not made available earlier and trace its journey from the lab in Winnipeg where it was developed, to its clinical trials in Guinea and its licensing to pharmaceutical giant Merck. We expose the hard realities behind some of the pharmaceutical industry’s choices and examine whether the world is now better prepared for the next epidemic.

»»» Subscribe to CBC News to watch more videos:

Connect with CBC News Online:

For breaking news, video, audio and in-depth coverage:
Find CBC News on Facebook:
Follow CBC News on Twitter:
For breaking news on Twitter:
Follow CBC News on Instagram:

Download the CBC News app for iOS:
Download the CBC News app for Android:

For more than 75 years, CBC News has been the source Canadians turn to, to keep them informed about their communities, their country and their world. Through regional and national programming on multiple platforms, including CBC Television, CBC News Network, CBC Radio,, mobile and on-demand, CBC News and its internationally recognized team of award-winning journalists deliver the breaking stories, the issues, the analyses and the personalities that matter to Canadians.